BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10888366)

  • 1. Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis.
    Weishaupt A; Gold R; Hartung T; Gaupp S; Wendel A; Brück W; Toyka KV
    J Neuropathol Exp Neurol; 2000 May; 59(5):368-76. PubMed ID: 10888366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schwann cell apoptosis in experimental autoimmune neuritis of the Lewis rat and the functional role of tumor necrosis factor-alpha.
    Weishaupt A; Brück W; Hartung T; Toyka KV; Gold R
    Neurosci Lett; 2001 Jun; 306(1-2):77-80. PubMed ID: 11403962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ.
    Weishaupt A; Schönrock LM; Stienekemeier M; Toyka KV; Gold R
    Acta Neuropathol; 2001 Jul; 102(1):75-82. PubMed ID: 11547954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
    Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
    Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
    Zhu J; Zou LP; Bakhiet M; Mix E
    J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
    Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
    Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.
    Weishaupt A; Gold R; Gaupp S; Giegerich G; Hartung HP; Toyka KV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1338-43. PubMed ID: 9037054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental autoimmune neuritis by leflunomide.
    Korn T; Toyka K; Hartung HP; Jung S
    Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
    Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
    Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis.
    Gold R; Oelschläger M; Pepinsky RB; Sommer C; Hartung HP; Toyka KV
    Acta Neuropathol; 1999 Dec; 98(6):583-9. PubMed ID: 10603033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats.
    Zou LP; Deretzi G; Pelidou SH; Levi M; Wahren B; Quiding C; van der Meide P; Zhu J
    Neuropharmacology; 2000 Jan; 39(2):324-33. PubMed ID: 10670428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis.
    De La Hoz CL; Castro FR; Santos LM; Langone F
    Neuroimmunomodulation; 2010; 17(1):56-66. PubMed ID: 19816058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat.
    Zettl UK; Gold R; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):540-7. PubMed ID: 7602327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies.
    Schmidt J; Elflein K; Stienekemeier M; Rodriguez-Palmero M; Schneider C; Toyka KV; Gold R; Hünig T
    J Neuroimmunol; 2003 Jul; 140(1-2):143-52. PubMed ID: 12864982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental allergic neuritis: cytolysin mRNA expression is upregulated in lymph node cells during convalescence.
    Zhu J; Bai XF; Mix E; Link H
    J Neuroimmunol; 1997 Sep; 78(1-2):108-16. PubMed ID: 9307234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
    Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
    J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice.
    Mao XJ; Zhang XM; Zhang HL; Quezada HC; Mix E; Yang X; Winblad B; Adem A; Zhu J
    Neurosci Lett; 2010 Feb; 470(1):19-23. PubMed ID: 20035831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.